Our Team

Serving as CGO, Andrea drives the commercial development process with customers focused on the introduction of novel formulations and ingredients involving both major and emerging cannabinoids, as well as product lines containing a full spectrum or specific phytocannabinoid ratios that are 100% THC free. She is the key liaison between customers, industry and academic research collaborators, and PPM’s R&D and product development teams. She also leads PPM’s marketing initiatives and relationship building with hemp industry companies and regulatory agencies. She is motivated to change each person’s world for the better and do so in each interaction, as well as with products created with scientific innovation. Pushing all team members at PPM to higher levels is one of Andrea’s superpowers which in turn helps PPM bring its customers and end-use consumers the benefits of new and efficacious cannabinoid-based products.

Dr. Andrea Holmes received her Ph.D. in organic chemistry at New York University and was a National Institutes of Health post-doctoral Fellow at Columbia University in the Department of Chemistry and Columbia Medical College, College of Physicians and Surgeons in New York City. She is a Professor of Chemistry at Doane University in Nebraska and holds appointments at the University of Nebraska in Lincoln and the University of Nebraska Medical Center. She was the recipient of the Presidential Early Career Award that was funded by the National Science Foundation and a national recipient of Henry Dreyfus Teacher Scholar award. Andrea published over 60 articles on nano-structured materials, miniaturized sensors, surface modifications for antimicrobial resistance, and has developed colorimetric sensors to detect warfare agents, abused narcotics, and cannabinoids.

Serving as CSO, David leads PPM’s science “factory” that is inspired by the philosophy of Edison’s original industrial research lab. Dave executes PPM’s research and development equivalent to other world-renowned, science advancing chemistry, and pharmaceutical research institutions. Taking innovation to commercialization through process and scale development is also Dave’s forte and responsibility. He leads inquiry into PPM’s scientific and customer-specific research work to increase bioavailability and enhancing terpenes, terpenoid and flavonoid profiles. His background in synthetic organic and organometallic chemistry provides the foundation for advancing both isolation and purification of unique cannabinoid ratios that become ingredients in novel hemp-derived phytocannabinoid products.

A former medicinal chemist and top producer at one of the largest pharmaceutical companies in the world, Dave’s understanding of both pharmacokinetics and bioavailability contribute to PPM’s ever-expanding product line. The PPM company principles of safety, efficacy, quality and consistency are foremost priorities in Dave’s scientific approach. Dave earned a Masters in Synthetic Organic Chemistry at the University of Nebraska and has worked for several companies including Novartis and Rieke Metals. David most recently founded and served as the CEO at Novel Chemical Solutions. He is tireless, creative, a first principal thinker,continuously experimenting, and discovering innovative techniques and methodologies to enhance PPM’s proprietary processes so they meet the exacting standards of both PPM customers and the people whose quality of life is improved by non-psychotropic phytocannabinoids.

Serving as COO, Steve executes PPM’s strategy of becoming the leading non-psychotropic cannabinoid-based ingredient supplier globally. He delivers results through his engaged leadership style and creative insight. His depth of experience, keen operational oversight, and dedication to advancing PPM’s science-based approach to extraction, refinement and purification provides him with great fulfillment knowing he is contributing to humankind by getting the most out of the complex cannabis plant to help people improve the quality of their lives.

Steve, a decisive and resolute leader, has over 20+ years of executive operational experience and demonstrated expertise in the development, management and positioning of complex manufacturing and production facilities in the dietary supplement industry. Steve earned a bachelor’s degree in Chemistry from the University of New Mexico and served as the principal partner for Pure Cultures, strategically developing its business model to provide distributors with high-quality probiotic options, and silage inoculants from concept to shelf. Previously, he worked at other microbiome and plant-based science-based companies in the Colorado biotechnology community including Hauser Chemical Research manufacturing the Taxol chemotherapy drug and Nutraceutix.

Serving as working Chairman, David’s primary responsibility is to provide the environment and resources for PPM’s scientists to advance the science of non-psychotropic cannabinoids. David also fosters strategic relationships with industry-leading growers, seed and genetics labs, researchers, and other hemp-based businesses. David views PPM as a transformative company which brings together a world-class group of employees who share PPM’s vision of improving health with new, distinctive, traceable, safe, consistent, and bioavailable plant-based wellness ingredients for the supply chains of consumer products companies.

David has been involved in corporate management and financing for over three decades in a wide variety of industries both in the private equity and venture capital worlds. He has also served in leadership roles at high growth businesses, both on an interim and permanent basis. David has been a lead board member on numerous private company and non-profit boards for enterprises with sales of $1 million to over $1 billion. David is a founding partner of Lynwood Capital Partners and has a dual degree from Yale University in economics and mechanical engineering.